Navigation Links
IRIDEX Reports 2011 Fourth Quarter and Year-End Results
Date:3/1/2012

statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended, relating to the Company's growth strategy, MicroPulse laser therapy, revenue growth and the Company's projected fiscal 2012 financial results.  These statements are not guarantees of future performance and actual results may differ materially from those described in these forward-looking statements as a result of a number of factors.  Please see a detailed description of these and other risks contained in our Annual Report on Form 10-K for the fiscal year ended January 1, 2011 and our Quarterly Reports on Form 10-Q for the quarters ended April 2, 2011, July 2, 2011 and October 1, 2011, each of which was filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and will not be updated.TABLES FOLLOWIRIDEX CorporationCondensed Consolidated Statements of Operations(In thousands, except per share data)

(unaudited)Three Months EndedTwelve Months EndedDecember 31,January 1, December 31,January 1, 2011201120112011Total revenues

$
8,620$
9,037$
33,159$
32,308Cost of revenues

4,3424,57316,86916,106Gross profit

4,2784,46416,29016,202Operating expenses:Research and development

1,1668853,9133,753Sales and marketing

2,1472,0947,4587,095General and administrative

1,0669234,2594,163Legal settlement, net of expenses

(1,274)-(1,274)-Total operating expenses

3,1053,90214,35615,011Income from operations

1,1735621,9341,191Other income (expense)Legal settlement

--800800Interest and other income (expense), net

(250)4(296)(30)Total other income (expense)

(250)4504770Income from continuing operations before income taxes

9235662,4381,961Provision for income taxes

122322297308Income from continuing operations

8012442,1411,653Income (lo
'/>"/>

SOURCE IRIDEX Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. IRIDEX Announces Fourth Quarter and Full Year 2011 Conference Call and Release Date
2. IRIDEX MicroPulse™ Laser Therapy Enhances Visual Function in Patients with Central Serous Chorioretinopathy (CSC)
3. IRIDEX to Present at the Sidoti & Company New York Micro Cap Conference
4. Cutera and IRIDEX Announce Acquisition of IRIDEX Aesthetic Business Unit
5. 10-Year Study Demonstrates IRIDEX MicroPulse™ Laser Therapy Safe, Effective for Patients with Diabetic Macular Edema
6. IRIDEX Signs License and Distribution Agreement with Leader in Eye Care
7. IRIDEX Reports 2011 Third Quarter and Nine-Month Results
8. IRIDEX Announces Third Quarter 2011 Conference Call and Release Date
9. IRIDEX Launches New MicroPulse™ Module Targeting the Broad Ophthalmology Laser Photocoagulation Market
10. IRIDEX Names Veteran Healthcare Executive Dominik Beck President, CEO
11. IRIDEX Licenses the Exclusive Rights to Ophthalmology Products and Intellectual Property from Ocunetics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Sept. 19, 2014 The Parenteral Drug Association ... global post-approval changes protocols. The new ... topic expressed by industry participants and regulatory authority representatives ... month in Washington, DC . Representatives ... hand for the workshop. Attendees indicated openness to engaging ...
(Date:9/19/2014)... DALLAS , Sept. 19, 2014 ... Market Outlook to 2020″, provides key ... General Surgery devices market. The report ... dollars, and volume (in units) within ... Cystoscopes, Colonoscopes, Sigmoidoscopes, Esophagoscopes & Gastroscopes, ...
(Date:9/19/2014)... 19, 2014  The board of directors of AbbVie ... cash dividend of $0.42 per share.  ... stockholders of record at the close of business on ... a global, research-based biopharmaceutical company formed in 2013 following ... its expertise, dedicated people and unique approach to innovation ...
Breaking Medicine Technology:PDA Launches Effort to Harmonize Global Post-Approval Changes Protocols 2United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 2United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 3United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 4United States General Surgery Devices Market to 2020 - Endoscopy, Bariatric Surgery, Aesthetic Lasers and Energy, Biopsy Devices, Hernia Repair, Non-Vascular Stents 5
... , the leader in heart rate monitoring and fitness assessment ... Rate Technology Supplier" for U.S. Soccer through 2013.  ... major national and international events, including the London 2012 Olympic ... be used to help these nine National Teams gain a ...
... Feb. 29, 2012  Four Rivers Software Systems, Inc. the ... to the healthcare industry, is pleased to announce ... part of this critical release, we have included ... that will benefit users.  The ...
Cached Medicine Technology:Polar Named Official Heart Rate Technology Supplier of U.S. Soccer Federation 2Polar Named Official Heart Rate Technology Supplier of U.S. Soccer Federation 3Four Rivers Software Systems Launches TMS 2012.5.5 2
(Date:9/19/2014)... who live in leafy, green neighborhoods are less likely to ... suggests. Researchers analyzed data from more than 64,000 births ... in a neighborhood with plenty of trees, grass and other ... birth (before 30 weeks) and a 13 percent lower risk ... born to mothers who lived in greener neighborhoods were also ...
(Date:9/19/2014)... U.S. Food and Drug Administration approved a new type 2 ... class of once-a-week injectable drugs that help manage blood sugar ... is a new treatment option, which can be used alone ... levels in the overall management of type 2 diabetes," Dr. ... Evaluation II, said in an agency news release. ...
(Date:9/19/2014)... Washington, DC (PRWEB) September 19, 2014 ... announced an important partnership with the National Fire ... fire safety. The collaboration, formalized today in a ... empower Alliance Members, factories, workers and other stakeholders ... that will help protect the health and safety ...
(Date:9/19/2014)... MetroMD, a leading anti-ageing clinic has called its HGH ... therapy has grown tremendously across USA in the last decade ... dependable. It has far reaching benefits for ageing men and ... healthy and active lifestyle even beyond their middle age. ... at MetroMD said, “HGH or Human Growth hormones are the ...
(Date:9/19/2014)... September 19, 2014 "I have difficulty ... wrinkles due to stretching the skin around my eyes ... "This inspired me to design a more convenient method ... LENS SYSTEM provides a quicker, easier, more sanitary method ... to perform this task manually, saves time and effort, ...
Breaking Medicine News(10 mins):Health News:Do Greener Neighborhoods Produce Healthier Babies? 2Health News:FDA Approves Another Weekly Injectable Drug for Type 2 Diabetes 2Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 2Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 3Health News:MetroMD Announces Better HGH Therapy - the ‘God Particle’ of Human Health 2
... Company Locations in Alabama, Georgia, Indiana, Iowa, Kansas, ... Texas, Virginia and WisconsinWASHINGTON, Jan. 15 SouthernCare ... the United States a total of $24.7 million ... submitted false claims to the government for patients ...
... coalition of clergy and lay members from faith organizations throughout ... Senator Richard Burr to end his opposition to legislation that ... over tobacco products. The legislation would protect kids from ... to filibuster the legislation if it was brought to the ...
... required for foods from these animals, agency says , , ... and Drug Administration on Thursday issued its final regulations ... rules do not require consumer labeling for foods from ... (rDNA) to introduce new characteristics or traits into an ...
... 15 Boston Scientific Corporation (NYSE: BSX ) today ... Circuit. The case involves a Boston Scientific patent, which in ... the decision, the Court found that the patent was invalid as ... by Johnson and Johnson of a 2005 jury verdict in the ...
... of Trade Alerts on stocks making news today. Investors can ... visiting: http://www.BeaconEquity.com/m Today,s Trade Alerts include: Eli Lily ... (NYSE: PCS ), ConAgra Foods Inc. (NYSE: ... ), Target Corp. (NYSE: TGT ) and Dow ...
... around 50 percent, despite proven benefits, report says , , THURSDAY, ... colon cancer saves lives, but too few Americans are getting ... report shows. , The rate of screening for breast and ... the rate of colorectal cancer screening has increased but not ...
Cached Medicine News:Health News:Alabama-Based Hospice Company Pays U.S. $24.7 Million to Settle Health Care Fraud Claims 2Health News:North Carolina Faith Leaders Call on Sen. Burr to End Filibuster Threat of Legislation to Protect Kids From Tobacco 2Health News:North Carolina Faith Leaders Call on Sen. Burr to End Filibuster Threat of Legislation to Protect Kids From Tobacco 3Health News:FDA Issues Final Regulations for Genetically Engineered Animals 2Health News:FDA Issues Final Regulations for Genetically Engineered Animals 3Health News:Boston Scientific Announces Court Decision 2Health News:Boston Scientific Announces Court Decision 3Health News:Beacon Equity Issues Technical Trade Alerts on Headline Stocks: LLY, PCS, CAG, FRX, TGT, DOW 2Health News:More Americans Urged to Get Cancer Screenings 2Health News:More Americans Urged to Get Cancer Screenings 3
BD Vacutainer® Heparin Tubes are spray-coated with either lithium heparin or sodium heparin and are used for plasma determinations in chemistry....
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
... Coagulation tubes contain a buffered ... available with a citrate concentration ... 0.129 mol/l (3.8%). The mixing ... solution to 9 parts blood. ...
... are available in two versions. ... a clotting activator and is ... serum is required for testing ... is suitable where the testing ...
Medicine Products: